"Feb. 20, 2013 -- More American women are aware of their risk for heart disease than ever before, but huge gaps in knowledge still remain.
A new survey shows that the number of women who know that heart disease is their leading cause o"...
TNKase (tenecteplase) therapy in patients with acute myocardial infarction is contraindicated in the following situations because of an increased risk of bleeding (see WARNINGS):
- Active internal bleeding
- History of cerebrovascular accident
- Intracranial or intraspinal surgery or trauma within 2 months
- Intracranial neoplasm, arteriovenous malformation,or aneurysm
- Known bleeding diathesis
- Severe uncontrolled hypertension
Last reviewed on RxList: 11/6/2008
Additional Tnkase Information
Report Problems to the Food and Drug Administration
Get the latest treatment options.